STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
19 hedge funds and large institutions have $661K invested in Statera Biopharma, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.
Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
$30K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$15K |
3 |
3
Morgan Stanley
New York
|
$12K |
4 |
4
Millennium Management
New York
|
$20 |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$407K |
2 |
2
Barclays
London,
United Kingdom
|
$15K |
3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$7K |
4 |
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
|
$33K |